- Home
- MBIN vs OCS Comparison
MBIN vs OCS Comparison
Compare MBIN & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBIN | OCS |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MBIN | OCS |
|---|---|---|
| Price | $41.76 | $25.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $43.67 | $41.86 |
| AVG Volume (30 Days) | 241.4K | ★ 381.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $31.76 | $418.43 |
| Revenue Next Year | $3.73 | $892.34 |
| P/E Ratio | $12.29 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.25 | $14.00 |
| 52 Week High | $48.50 | $30.68 |
Technical Indicators
Market Signals| Indicator | MBIN | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 38.55 |
| Support Level | $30.89 | $19.00 |
| Resistance Level | $48.50 | $29.23 |
| Average True Range (ATR) | 1.38 | 1.31 |
| MACD | -0.44 | -0.43 |
| Stochastic Oscillator | 37.71 | 4.55 |
Price Performance
Historical ComparisonAbout MBIN Merchants Bancorp
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.